What Is Phoenix Stack?
The Phoenix Stack is a synergistic triad composed of BPC-157, TB-500, and KPV. While BPC-157 and TB-500—collectively known as the "Wolverine" stack—provide a foundation for robust tissue repair, angiogenesis, and musculoskeletal recovery, the addition of KPV (a tripeptide derived from α-MSH) expands the protocol's scope. By integrating KPV, the stack provides systemic anti-inflammatory and mucosal healing coverage, specifically targeting gut health, skin integrity, and immune modulation.
The name "Phoenix" symbolizes comprehensive, full-body renewal. It is designed for complex recovery needs, including inflammatory injuries, IBD-adjacent support, and the management of systemic inflammatory loads. By combining the structural regenerative capabilities of BPC-157 and TB-500 with the targeted immunomodulatory effects of KPV, the stack offers a multi-pathway approach to recovery and systemic homeostasis.
Mechanism of Action
BPC-157 upregulates growth factors such as VEGF and EGF, promoting angiogenesis via nitric oxide modulation while protecting GI mucosa [L4]. TB-500 utilizes the LKKTET motif to sequester G-actin, facilitating the migration of fibroblasts and immune cells to injury sites to reduce scarring and accelerate tissue repair [L11]. KPV binds to MC1R and MC3R receptors, effectively downregulating NF-κB, IL-6, and TNF-α signaling while inhibiting mast cell degranulation and fostering epithelial healing [L8].
Together, these peptides operate through distinct, complementary pathways with no receptor competition, allowing for a highly coordinated response to both acute mechanical injury and chronic inflammatory states.
Structural Repair and Tissue Regeneration
The Phoenix Stack leverages the well-documented synergy between BPC-157 and TB-500 for musculoskeletal health. BPC-157 promotes collagen organization, fibroblast migration, and increased tensile strength in tendons, ligaments, and bone [L5]. Concurrently, TB-500 acts as a potent regulator of cell motility, ensuring that endothelial and progenitor cells are efficiently recruited to wound sites to drive tissue regeneration [L11]. This combination enhances angiogenesis through coordinated upregulation of VEGF and VEGFR2 [L4, L9], creating an optimal physiological environment for repairing damaged structural tissues.
Inflammation Resolution and Mucosal Healing
KPV serves as a critical bridge in the stack, providing superior mucosal healing and potent anti-inflammatory properties that complement the regenerative base. In the GI tract, KPV reduces colonic inflammation and improves mucosal integrity, which pairs effectively with BPC-157's gastrointestinal protective effects [L2, L6]. By inhibiting pro-inflammatory cytokines like TNF-α and IL-6 [L8], KPV mitigates the chronic inflammatory environment that often hinders effective repair, while TB-500 further minimizes the formation of fibrous scar tissue, ensuring that structural repair is functional rather than merely reparative [L9, L11].
Quick Reference
Member reference tables summarize the compound's research parameters.
Research Indications
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Peptide Interactions
This member section summarizes reported compound interactions and evidence limitations.
Reported Research Time Points
This member section summarizes reported research time points.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
Quality Indicators
Research Citations
- Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review
Jóźwiak, M., Bauer, M., Kamysz, W., Kleczkowska, P., 2025, Pharmaceuticals - Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Seiwerth, S., Milavic, M., Vukojevic, J., et al., 2021, Frontiers in Pharmacology - Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
Hsieh, M.J., Liu, H.T., Wang, C.N., et al., 2017, Journal of Molecular Medicine - Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth
Staresinic, M., Sebecic, B., Patrlj, L., et al., 2003, Journal of Orthopaedic Research - The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang, C.H., Tsai, W.C., Lin, M.S., Hsu, Y.H., Pang, J.H., 2011, Journal of Applied Physiology - Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157
Staresinic, M., Petrovic, I., Novinscak, T., et al., 2006, Journal of Orthopaedic Research - Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract
Sikiric, P., Seiwerth, S., Rucman, R., et al., 2011, Current Pharmaceutical Design - Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection
Sikiric, P., Hahm, K.B., Blagaic, A.B., et al., 2020, Gut and Liver - Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157
He, L., Feng, D., Guo, H., et al., 2022, Frontiers in Pharmacology - Pentadecapeptide BPC 157 and the central nervous system
Vukojevic, J., Milavić, M., Perović, D., et al., 2022, Neural Regeneration Research - Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats
Perovic, D., Kolenc, D., Bilic, V., et al., 2019, Journal of Orthopaedic Surgery and Research - Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds
Xu, C., Sun, L., Ren, F., et al., 2020, Regulatory Toxicology and Pharmacology - Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin
Pawar K, Kolli CS, Rangari VK, 2017, J Pharm Sci - Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway
Sung J, Ju SY, Park S, 2025, Tissue Cell - Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers
Cheng J, Wu P, Li C, 2026, Sci Adv - The neuroimmunomodulatory peptide alpha-MSH
Ichiyama T, Sato S, Okada K, 2000, Ann N Y Acad Sci - Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model
Laroui H, Dalmasso G, Nguyen HT, 2010, Gastroenterology - Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Mayfield CK, Bolia IK, Feingold CL, 2026, Am J Sports Med - Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry
Thomas A, Görgens C, Guddat S, 2016, J Sep Sci